
Snego Pharmaceuticals Private Limited
About Snego Pharmaceuticals Private Limited
Data last updated:
Snego Pharmaceuticals Private Limited is a private limited company based in Via-Danpur, Odisha, India, recognised as a startup by DPIIT. It operates in the diversified business activities segment of the business services sector. It was incorporated on 11 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U74999OR2018PTC028200. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Ashwin Kumar Mohanty and Gourabananda Routray.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No 341 Gokulananda Routray House At – Tirinia Po – Indalo, Via – Danpur, Odisha, India – 754210.
As per the financials filed for FY 2023, the company reported a revenue of ₹3.21 Lakh, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹1,420 (net margin 0.4%) and EBITDA of ₹1.08 Lakh (EBITDA margin 33.6%). Revenue has declined at a compounded annual rate (CAGR) of 38% over three years.
Company details
Recognitions & Rankings of Snego Pharmaceuticals
Contact details
Snego Pharmaceuticals Private Limited's registered office is in Via-Danpur, Odisha. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No 341 Gokulananda Routray House At – Tirinia Po – Indalo, Via – Danpur, Odisha, India – 754210
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Snego Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Snego Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Snego Pharmaceuticals Private Limited, buy the company report.
Financials of Snego Pharmaceuticals Private Limited
FY 2023 filings availableSnego Pharmaceuticals Private Limited reported revenue of ₹3.21 Lakh (down 23% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 38% over three years, including a 23% fall in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,420 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 33.6% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Snego Pharmaceuticals Private Limited, buy the company report.
Board of directors of Snego Pharmaceuticals Private Limited
Snego Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashwin Kumar Mohanty | Director | 07 Sep 2020 | 6 Years 1 Months | Current |
| Gourabananda Routray | Director | 11 Jan 2018 | 8 Years 9 Months | Current |
| Gyanananda Routray | Director | 11 Jan 2018 | 8 Years 9 Months | Current |
Peer comparison
Snego Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fysan Pharmaceuticals Private Limited | ₹3.22 Lakh (FY 2020) | -62.0% | Pune, Maharashtra, India | |||
| Prickom Pharmaceuticals Private Limited | ₹3.22 Lakh (FY 2025) | 34.0% | Lucknow, Uttar Pradesh, India | |||
| Snego Pharmaceuticals Private Limitedthis company | ₹3.21 Lakh (FY 2023) | ₹1,420 | 0.4% | -23.0% | Via-Danpur, Odisha, India | |
| Vaishnav Pharmaceuticals Private Limited | ₹3.21 Lakh (FY 2024) | Nagpur, Maharashtra, India | ||||
| Aloves Med Pharmaceuticals Private Limited | ₹3.2 Lakh (FY 2024) | -66.0% | Nalasopara West, Maharashtra, India | |||
| Metkind Pharmaceuticals Private Limited | ₹3.19 Lakh (FY 2025) | Gorkhpur, Uttar Pradesh, India |
To see the full peer comparison of Snego Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Snego Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Snego Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Snego Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Snego Pharmaceuticals Private Limited, buy the company report.
Recent activity
Snego Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Ashwin Kumar Mohanty was appointed as Director on 07 Sep 2020.
Frequently asked questions
Snego Pharmaceuticals is an active private limited company based in Via-Danpur, Odisha, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 11 January 2018 (8+ years old) and is registered under CIN U74999OR2018PTC028200.
Snego Pharmaceuticals has 3 current directors:
- Ashwin Kumar Mohanty - Director
- Gourabananda Routray - Director
- Gyanananda Routray - Director
The latest financial statements of Snego Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
No. Snego Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Snego Pharmaceuticals is U74999OR2018PTC028200. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Snego Pharmaceuticals was incorporated on 11 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Snego Pharmaceuticals by revenue are Fysan Pharmaceuticals Private Limited, Prickom Pharmaceuticals Private Limited, Vaishnav Pharmaceuticals Private Limited, Aloves Med Pharmaceuticals Private Limited, Metkind Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ashwin Kumar Mohanty was appointed as Director on 07 Sep 2020. Gourabananda Routray was appointed as Director on 11 Jan 2018. Gyanananda Routray was appointed as Director on 11 Jan 2018.
Yes, Snego Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Snego Pharmaceuticals is at Plot No 341 Gokulananda Routray House At – Tirinia Po – Indalo, Via – Danpur, Odisha, India – 754210.
Snego Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.

